Accordingly, IGF2 expression levels were lower in paclitaxel sensitive breast cancer cells than in paclitaxel resistant breast cancer cells in GSE90564 (Figure 6F, p-value < 0.05). This evidence concerns the gene IGF2 and breast cancer.